137 related articles for article (PubMed ID: 37500718)
1. Use of calcium channel blockers does not increase breast cancer risk: findings from a nationwide population-based cohort study in Taiwan.
Minegishi S
Hypertens Res; 2023 Oct; 46(10):2312-2314. PubMed ID: 37500718
[No Abstract] [Full Text] [Related]
2. Use of calcium channel blockers and risk of breast cancer among women aged 55 years and older: a nationwide population-based cohort study.
Lin SY; Huang HY; Chiang LT; Huang LY; Wang CC
Hypertens Res; 2023 Oct; 46(10):2272-2279. PubMed ID: 37253976
[TBL] [Abstract][Full Text] [Related]
3. Effect of Antihypertensive Medications on Sepsis-Related Outcomes: A Population-Based Cohort Study.
Kim J; Kim YA; Hwangbo B; Kim MJ; Cho H; Hwangbo Y; Lee ES
Crit Care Med; 2019 May; 47(5):e386-e393. PubMed ID: 30688717
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive agents and the risk of breast cancer in women aged 55 years and older: a nested case-control study.
Chang CH; Chiang CH; Yen CJ; Wu LC; Lin JW; Lai MS
J Hypertens; 2016 Mar; 34(3):558-66; discussion 566. PubMed ID: 26818924
[TBL] [Abstract][Full Text] [Related]
5. Effect of antihypertensive drugs on breast cancer risk in female hypertensive patients: Evidence from observational studies.
Zhao Y; Wang Q; Zhao X; Meng H; Yu J
Clin Exp Hypertens; 2018; 40(1):22-27. PubMed ID: 29115847
[TBL] [Abstract][Full Text] [Related]
6. Compliance of Antihypertensive Medication and Risk of Coronavirus Disease 2019: a Cohort Study Using Big Data from the Korean National Health Insurance Service.
Kim J; Kim DW; Kim KI; Kim HB; Kim JH; Lee YG; Byeon KH; Cheong HK;
J Korean Med Sci; 2020 Jun; 35(25):e232. PubMed ID: 32597045
[TBL] [Abstract][Full Text] [Related]
7. Long-term use of calcium channel blocking drugs and breast cancer risk in a prospective cohort of US and Puerto Rican women.
Wilson LE; D'Aloisio AA; Sandler DP; Taylor JA
Breast Cancer Res; 2016 Jul; 18(1):61. PubMed ID: 27378129
[TBL] [Abstract][Full Text] [Related]
8. Long-term Effects of Antihypertensive Drug Use and New-onset Osteoporotic Fracture in Elderly Patients: A Population-based Longitudinal Cohort Study.
Chen HY; Ma KY; Hsieh PL; Liou YS; Jong GP
Chin Med J (Engl); 2016 Dec; 129(24):2907-2912. PubMed ID: 27958221
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive Drug Use and New-Onset Diabetes in Female Patients with Coronary Artery Disease: A Population-based Longitudinal Cohort Study.
Liou YS; Chen HY; Tien L; Gu YS; Jong GP
Medicine (Baltimore); 2015 Sep; 94(36):e1495. PubMed ID: 26356715
[TBL] [Abstract][Full Text] [Related]
10. Long-term effects of antihypertensive drugs on the risk of new-onset diabetes in elderly Taiwanese hypertensives.
Liou YS; Ma T; Tien L; Chien C; Chou P; Jong GP
Int Heart J; 2008 Mar; 49(2):205-11. PubMed ID: 18475020
[TBL] [Abstract][Full Text] [Related]
11. A cohort study of antihypertensive medication use and breast cancer among Danish women.
Fryzek JP; Poulsen AH; Lipworth L; Pedersen L; Nørgaard M; McLaughlin JK; Friis S
Breast Cancer Res Treat; 2006 Jun; 97(3):231-6. PubMed ID: 16791484
[TBL] [Abstract][Full Text] [Related]
12. Use of Calcium Channel Blockers and Risk of Breast Cancer: A Population-based Cohort Study.
Azoulay L; Soldera S; Yin H; Bouganim N
Epidemiology; 2016 Jul; 27(4):594-601. PubMed ID: 27031042
[TBL] [Abstract][Full Text] [Related]
13. Do calcium channel blockers increase the risk of cancer?
Pahor M; Guralnik JM; Salive ME; Corti MC; Carbonin P; Havlik RJ
Am J Hypertens; 1996 Jul; 9(7):695-9. PubMed ID: 8806983
[TBL] [Abstract][Full Text] [Related]
14. Risk of Breast Cancer With Long-Term Use of Calcium Channel Blockers or Angiotensin-Converting Enzyme Inhibitors Among Older Women.
Raebel MA; Zeng C; Cheetham TC; Smith DH; Feigelson HS; Carroll NM; Goddard K; Tavel HM; Boudreau DM; Shetterly S; Xu S
Am J Epidemiol; 2017 Feb; 185(4):264-273. PubMed ID: 28186527
[TBL] [Abstract][Full Text] [Related]
15. Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years.
Li CI; Malone KE; Weiss NS; Boudreau DM; Cushing-Haugen KL; Daling JR
Cancer; 2003 Oct; 98(7):1504-13. PubMed ID: 14508839
[TBL] [Abstract][Full Text] [Related]
16. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
Talbert RL
J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive Use and the Risk of Cataract in Patients with Hypertension: A Nationwide Case-control Study.
Yang HL; Byun SJ; Park S; Lee SH; Park SJ; Jung SY
Ophthalmic Epidemiol; 2023 Oct; 30(5):499-508. PubMed ID: 36369827
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin receptor blockers and risk of cancer: cohort study among people receiving antihypertensive drugs in UK General Practice Research Database.
Bhaskaran K; Douglas I; Evans S; van Staa T; Smeeth L
BMJ; 2012 Apr; 344():e2697. PubMed ID: 22531797
[TBL] [Abstract][Full Text] [Related]
19. Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic.
Volpe M; Tocci G
Vasc Health Risk Manag; 2012; 8():371-80. PubMed ID: 22745561
[TBL] [Abstract][Full Text] [Related]
20. Use of Antihypertensive Medications Not Associated with Risk of Contralateral Breast Cancer among Women Diagnosed with Estrogen Receptor-Positive Invasive Breast Cancer.
Chen L; Malone KE; Li CI
Cancer Epidemiol Biomarkers Prev; 2015 Sep; 24(9):1423-6. PubMed ID: 26084603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]